• Publications
  • Influence
The Fab Fragment of a Novel Anti-GPVI Monoclonal Antibody, OM4, Reduces In Vivo Thrombosis Without Bleeding Risk in Rats
Background—Inhibition of GPVI has been proposed as a useful antithrombotic strategy; however, in vivo proof-of-concept animal studies targeting GPVI are lacking. We evaluated a novel anti-human GPVIExpand
  • 55
  • 2
Antiplatelet and Antithrombotic Activity of Cilostazol is Potentiated by Dipyridamole in Rabbits and Dissociated from Bleeding Time Prolongation
Purpose: To determine the antiplatelet effect of cilostazol (Pletal®) and its interaction with dipyridamole in in vitro and in vivo rabbit models, and to see if it can be dissociated from bleedingExpand
  • 11
GW29-e0695 Diagnostic Accuracy of High-sensitivity Cardiac Troponin I for Myocardial Infarction in ICU Patients Except Cardiovascular Department
High-sensitivity Cardiac Troponin I (hs-cTnI) above the 99th percentile of a healthy reference population (hs-cTnI >0.034ng/ml in our laboratory) can be diagnosed myocardial infarction (MI),Expand